Immunoglobulin free light chains: an inflammatory biomarker of diabetes.

Akira MatsumoriToshio ShimadaMiho ShimadaMark T Drayson

Published in: Inflammation research : official journal of the European Histamine Research Society ... [et al.] (2020)

These results suggest that FLC kappa/lambda may be more specific and sensitive for the diagnosis of T2D than HbA1c, and thus represents a potentially promising biomarker of inflammation.

Keyphrases

oxidative stress
type diabetes
nuclear factor
cardiovascular disease
glycemic control
immune response
toll like receptor